{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T09:33:00Z","timestamp":1747215180613,"version":"3.40.5"},"reference-count":16,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:p> BACKGROUND: Optimal timing for Pneumocystis jirovecii pneumonia (PCP) prophylaxis among patients with vasculitis is not clear. We set out to characterize the clinical presentation and duration of prednisone use before the development of PCP among these patients. METHODS: All patients with PCP at The Ottawa Hospital (TOH) between 2006 and 2017 were identified. Using TOH data repositories, the following data were extracted: prednisone dosage, treatment duration, other immunosuppressive medications, PCP prophylaxis, PCP treatment, and death. Data were reported as median and range or as mean and standard deviation. RESULTS: We identified seven patients (5 men, 2 women) with biopsy-proven vasculitis who developed PCP: six with anti-neutrophil cytoplasmic antibody\u2013associated vasculitis and one with giant cell arteritis. None of the patients were on PCP prophylaxis. The most common symptoms on presentation were cough and dyspnea. At diagnosis, the median lymphocyte count was 0.30 \u00d7 10<jats:sup>9<\/jats:sup>\/L (range 0.03\u20132.10), creatinine was 186 \u00b5mol\/L (range 78\u2013359), and lactate dehydrogenase was 471 U\/L (range 301\u20131032). All patients were on prednisone at time of PCP diagnosis, with six on doses of \u226520 mg\/day for at least 12 weeks. All but one patient were on additional immunosuppressants, with cyclophosphamide being the most common agent for five of the seven patients. Four (57%) required intensive care unit admission, and two (29%) died secondary to complications of PCP. CONCLUSIONS: PCP is a severe and often fatal opportunistic infection among immunocompromised patients with vasculitis. Frequent evaluation of the need for prophylaxis is required for patients who remain on high-dose steroids and concomitant immunosuppressants. <\/jats:p>","DOI":"10.3138\/jammi-2021-0031","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T18:33:36Z","timestamp":1644258816000},"page":"117-124","source":"Crossref","is-referenced-by-count":0,"title":["Duration of prednisone treatment before development of <i>Pneumocystis jirovecii<\/i> pneumonia in patients with vasculitis: A case series"],"prefix":"10.3138","volume":"7","author":[{"given":"Ieta","family":"Shams","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ivory","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Centre of Infection, Immunity and Inflammation, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-5109","authenticated-orcid":true,"given":"Juthaporn","family":"Cowan","sequence":"additional","affiliation":[{"name":"Centre of Infection, Immunity and Inflammation, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Clinical Epidemiology, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Division of Infectious Diseases, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"3","key":"r1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/eci.12410","volume":"45","author":"Kronbichler A","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"r2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/ar2826","volume":"11","author":"Moosig F","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"r3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","volume":"183","author":"Limper AH","year":"2011","journal-title":"Am J Resp Crit Care Med"},{"issue":"4","key":"r4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.090843","volume":"37","author":"Cettomai D","year":"2010","journal-title":"J Rheumatol"},{"issue":"5","key":"r5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/annrheumdis-2017-212588","volume":"77","author":"Winthrop KL","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"r6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"Yale SH","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"r7","first-page":"R527","volume":"269","author":"Coelho MM","year":"1995","journal-title":"Am J Physiol"},{"issue":"10","key":"r8","first-page":"CD005590","author":"Stern A","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"r9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s10067-018-4155-6","volume":"37","author":"Matraiah EH","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"9","key":"r10","doi-asserted-by":"crossref","first-page":"e0239042","DOI":"10.1371\/journal.pone.0239042","volume":"15","author":"Zalmanovich A","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"r11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/acr.20435","volume":"63","author":"Kermani TA","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"r12","first-page":"S-122","volume":"33","author":"Berger CT","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"r13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/art.20082","volume":"51","author":"Bligny D","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"r14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/15.5.611","volume":"15","author":"Aasar\u00f8d K","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"r15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","volume":"42","author":"Ward MM","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"12","key":"r16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/ard.54.12.991","volume":"54","author":"Godeau B","year":"1995","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2021-0031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:00:30Z","timestamp":1741878030000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2021-0031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6,1]]}},"alternative-id":["10.3138\/jammi-2021-0031"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2021-0031","relation":{},"ISSN":["2371-0888","2371-0888"],"issn-type":[{"type":"print","value":"2371-0888"},{"type":"electronic","value":"2371-0888"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}